Target intelligence / Profile preview

Cytohesin-3 (CYTH3)

Target
CYTH3
Molecular classification
Guanine-nucleotide exchange factor (GEF), Regulatory protein for small GTPases (specifically ARF subfamily), Coiled-coil domain-containing protein, Pleckstrin homology domain-containing protein
01

Overview

Cytohesin-3 (CYTH3) is a guanine-nucleotide exchange factor (GEF) belonging to the cytohesin/PSCD protein family, characterized by an N-terminal coiled-coil motif, a central Sec7 GEF domain, and a C-terminal pleckstrin homology (PH) domain. It promotes guanine-nucleotide exchange on ARF GTPases (particularly ARF1 and ARF6), facilitating their activation by exchanging GDP for GTP. Cytohesin-3 plays a role in regulating Golgi structure and function, mediating protein sorting, membrane trafficking, and epithelial cell polarity. It localizes to multiple subcellular compartments, including the cytosol, plasma membrane, Golgi membrane, nucleoplasm, and cell junctions. Genetic and functional associations link CYTH3 to several biologically and clinically relevant processes, although no specific pharmacological modulators or approved interacting drugs are documented to date.

Other names
Cytohesin 3ARNO3PSCD3GRP1Protein ARNO3General receptor of phosphoinositides 1ARF nucleotide-binding site opener 3PH, SEC7 and coiled-coil domain-containing protein 3Pleckstrin homology Sec7 and coiled-coil domains 3Cytohesin-3CYTH3
02

Mechanism of action

If targeted, drugs would be expected to inhibit guanine-nucleotide exchange activity on ARF1/ARF6, affecting vesicle trafficking and ARF signaling. This is an inference based on the established biological activity of the protein.

03

Biological functions

Regulation of ADP-ribosylation factor (ARF) protein signal transduction (specifically ARF1 and ARF6)Protein sortingMembrane traffickingControl of Golgi apparatus structure and functionEstablishment of epithelial cell polarityPositive regulation of cell adhesion
04

Disease associations

Cancer (possible, but specific mechanisms or roles are not well established)Schizophrenia (association reported)X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia (reported association)Shigella infectionSleep-wake schedule disorder (reported association)Other (roles in specific disease pathways still under investigation)
05

Safety considerations

No specific safety concerns or therapeutic challenges described in the available literature as of now.The physiological roles in trafficking and epithelial polarity imply potential for off-target effects in tissues reliant on vesicular and membrane dynamics.
06

Interacting drugs

No clinically approved drugs are known to selectively target Cytohesin-3 as of current knowledge. Research inhibitors or GEF modulators may exist, but these are not discussed in the provided sources and no approved or widely studied names are specified.
07

Biomarkers

No validated biomarkers reported for patient selection or efficacy monitoring based on the provided sources.

Beyond the preview

Go deeper on Cytohesin-3 (CYTH3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytohesin-3 (CYTH3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call